INDIGO Biosciences
Latest round
- Series B
Last raised
- Jun 2016
Total raised
- $0.5M
Investors
- 2
About INDIGO Biosciences
Founded in 2005 in State College, US, INDIGO Biosciences focuses on providing innovative assay solutions.5 mn from Allied Growth Strategies & Management and Life Sciences Greenhouse of Central Pennsylvania in June 2016.INDIGO Biosciences specializes in providing advanced in vitro assay solutions, primarily focusing on cell-based luciferase reporter assay kits that target various human receptors. Their offerings include kits for the Human Glucagon-Like Peptide-1 Receptor (GLP-1R), Human Fibroblast Growth Factor Receptor 3 (FGFR3), Human Dopamine Receptor D1 (DRD1), Human Glucagon Receptor (GCGR), and Human Gastric Inhibitory Polypeptide Receptor (GIPR). These kits help in screening test samples to measure functional activity against their respective receptors, aiding researchers in drug discovery.INDIGO Biosciences generates revenue through the sale of its specialized assay kits and services, primarily operating in a B2B model. Clients order these kits directly for research applications, often through one-time purchases with volume discounts. The company also provides pre-clinical non-GLP Lead Discovery and Optimization services, enhancing revenue by offering tailored scientific consultation.5 mn for future product development and market expansion. The company aims to introduce new assay kits targeting additional receptors by mid-2023, enhancing its product line. Additionally, INDIGO is focusing on expanding into European and Asian markets by late 2024 to increase its global footprint.
Who invested in INDIGO Biosciences
2 investors across 1 round
See all investors in INDIGO Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jun 28, 2016
Amount
$0.5M
Investors
Questions about INDIGO Biosciences
Who invested in INDIGO Biosciences?
INDIGO Biosciences has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has INDIGO Biosciences raised?
INDIGO Biosciences has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did INDIGO Biosciences last raise money?
INDIGO Biosciences's most recent round on record is a Series B, in Jun 2016.
What does INDIGO Biosciences do?
Founded in 2005 in State College, US, INDIGO Biosciences focuses on providing innovative assay solutions.
Where is INDIGO Biosciences headquartered?
INDIGO Biosciences is headquartered in State College, US.
Which VCs invest in companies like INDIGO Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at INDIGO Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like INDIGO Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.